Ixcela Biome Support

17-Strain Probiotic + Prebiotic

$109.99 for a 90-day supply
($36.66 per month)

One of the most diverse blends of probiotics on the market!

Free shipping in the U.S. for orders $200 or more.

Provided by Paypal CREDIT
Product Details

Ixcela Biome Support contains 30 billion colony forming units (CFU) and 17 different bacteria strains, making it one of the richest probiotics on the market. Biome Support was designed to support optimal levels of metabolites indole-3-propionic acid, indole-3-acetic acid, indole-3-lactic acid, tryptophan, tyrosine, serotonin, and total indoxyl sulfate.

Ixcela Biome Support uses an enteric capsule to protect the probiotic strains so that they can be delivered to the areas of the gut where they are needed most. This means that unlike many retail-store probiotics and the probiotics found in yogurts, kombucha, and fermented pickles, the bacterial strains in Ixcela Biome Support are able to pass through acidic regions of the stomach and make their way to the lower small intestine and large intestine to do their work. Biome Support also includes prebiotics (FOS and inulin), which help gut bacteria grow and thrive.*

Did you know that not all probiotics are created equal? Find out what makes a good probiotic and why Ixcela Biome Support stands apart from the rest!

As with any dietary supplement, consult your health care practitioner before using this product, especially if you have an immune deficiency or histamine intolerance, are pregnant or nursing, anticipating surgery, taking any medications on a regular basis, or are otherwise under medical supervision.

Ixcela supplements are formulated to exclude:

  • Gluten
  • Nuts
  • Preservatives
  • Corn
  • Wheat
  • Fish
  • Crustacean Shellfish
  • Added Colors
  • Soy
  • GMO
  • Dairy and Lactose
  • Eggs
  • Yeast
  • Sugars
  • Artificial Sweeteners

Ixcela supplements are produced at an FDA-registered, GMP-compliant facility and contain no harmful fillers. They are vegetarian and are not tested on animals.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Probiotics consist of live, beneficial bacterial microorganisms that can help repopulate the gut microbiome, especially after insult from antibiotics, stress, or poor diet. Ideally, probiotic supplements consist of a variety of different families (strains) of bacteria and/or yeasts. It is also important to have enough of these bacteria, which is why at least 25 billion colony forming units (CFU) is recommended. Ixcela Biome Support has 30 billion CFU.

Ixcela’s Probiotic Blend

Prebiotics serve as food for bacteria and can help them grow and thrive. The human body is not capable of digesting FOS and inulin fibers; however, bacteria can use the fibers as a substrate (food source) to live on. These same fibers can also assist in keeping bowels regular.

For adults only. Adults take one (1) capsule per day with a meal. If taking antibiotics: It is best to wait 2 hours after taking an antibiotic before taking Ixcela Biome Support.

After starting a new probiotic supplement, it is normal to notice mild GI symptoms; however, symptoms usually subside within a week or two. If your symptoms continue for several weeks or if you are very uncomfortable, consider reducing the number of days per week that you take the supplement. Consider reducing the supplement frequency to every other day for two weeks, and then begin to take the supplement every day.

Warning: Keep out of reach of children.

Caution: As with any dietary supplement, consult your health care practitioner before using this product, especially if you have an immune deficiency or histamine intolerance, are pregnant or nursing, anticipating surgery, taking any medications on a regular basis, or are otherwise under medical supervision.

Storage: Keep tightly closed. Store in a dry place and avoid excessive heat.

  • Jamilian, Mehri, et al. “Effects of Probiotic Supplementation on Metabolic Status in Pregnant Women: a Randomized, Double-Blind, Placebo-Controlled Trial.” Archives of Iranian Medicine, vol. 19, no. 10, 2016, pp. 687-692. doi: 0161910/AIM.004. www.ncbi.nlm.nih.gov/pubmed/27743432.
  • Steenbergen, Laura, et al. “A Randomized Controlled Trial to Test the Effect of Multispecies Probiotics on Cognitive Reactivity to Sad Mood.” Brain, Behavior, and Immunity, vol. 48, 2015, pp. 258-264. https://doi.org/10.1016/j.bbi.2015.04.003.
  • Cruchet, Sylvia, et al. “The Use of Probiotics in Pediatric Gastroenterology: a Review of the Literature and Recommendations by Latin-American Experts.” Paediatric Drugs, vol. 17, no. 3, 2015, pp. 199-216. https://doi.org/10.1007/s40272-015-0124-6.
  • d’Ettorre, Gabriella, et al. “Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the ‘Probio-HIV’ Clinical Trial.” PLoS ONE, vol. 10, no. 9, 2015. https://doi.org/10.1371/journal.pone.0137200.
  • Hwang, E-Nam, et al. “Screening of Immune-Active Lactic Acid Bacteria.” Korean Society for Food Science of Animal Resources, vol. 35, no. 4, 2015, pp. 541-550. http://dx.doi.org/10.5851/kosfa.2015.35.4.541.
  • Maldonado, J., et al. “Evaluation of the Safety, Tolerance and Efficacy of 1-Year Consumption of Infant Formula Supplemented with Lactobacillus Fermentum CECT5716 Lc40 or Bifidobacterium Breve CECT7263: A Randomized Controlled Trial.” BMC Pediatrics, vol. 19, no. 1, 2019. doi: 10.1186/s12887-019-1753-7. www.ncbi.nlm.nih.gov/pmc/articles/PMC6802336.
  • Cruchet, S., et al. “The Use of Probiotics in Pediatric Gastroenterology: a Review of the Literature and Recommendations by Latin-American Experts.” Paediatric Drugs, vol. 17, no. 3, 2015, pp. 199-216. doi: 10.1007/s40272-015-0124-6. www.ncbi.nlm.nih.gov/pubmed/25799959.
  • Mohammadi, Ali Akbar, et al. “Effects of Probiotics on Biomarkers of Oxidative Stress and Inflammatory Factors in Petrochemical Workers: A Randomized, Double-Blind, Placebo-Controlled Trial.” International Journal of Preventive Medicine, vol. 6, no. 1, 2015, pp. 82-109. doi: 10.4103/2008-7802.164146. www.ncbi.nlm.nih.gov/pubmed/26445629.
  • Dang, Y. et al. “The Effect of Probiotics Supplementation on Helicobacter Pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis.” PloS One, vol. 9, no. 11, 2014. doi: 10.1371/journal.pone.0111030. www.ncbi.nlm.nih.gov/pubmed/25365320.
  • Zambori, Csilla, et al. “Antimicrobial Effect of Probiotics on Bacterial Species from Dental Plaque.” The Journal of Infection in Developing Countries, vol. 10, no. 3, 2016, pp. 214-221. https://doi.org/10.3855/jidc.6800.
  • Waki, N., et al. “Effects of Probiotic Lactobacillus Brevis KB290 on Incidence of Influenza Infection among Schoolchildren: An Open-Label Pilot Study.” Letters in Applied Microbiology, vol. 59, 2014, pp. 565-571. doi: 10.1111/lam.12340. www.ncbi.nlm.nih.gov/pmc/articles/PMC4285317/.
  • Ashraf, Rabia and Shah, Nagendra P. “Immune System Stimulation by Probiotic Microorganisms.” Critical Reviews in Food Science and Nutrition, vol. 54, no. 7, 2014, pp. 938-956. doi: 10.1080/10408398.2011.619671. www.ncbi.nlm.nih.gov/pubmed/24499072.
  • Jäger, Ralf, et al. “Probiotic Streptococcus Thermophilus FP4 and Bifidobacterium Breve BR03 Supplementation Attenuates Performance and Range-of-Motion Decrements Following Muscle Damaging Exercise.” Nutrients, vol. 8, no. 10, 2016, pp. 642-653. doi: 10.3390/nu8100642. www.ncbi.nlm.nih.gov/pmc/articles/PMC5084029/